W STRATEGIES, LLC

Lobbying for BRISTOL-MYERS SQUIBB COMPANY · Biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $30,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Education about the value of biopharmaceutical innovation and related issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem